標(biāo)題: Titlebook: Breast Cancer Management for Surgeons; An Examination Guide Christos Markopoulos,Andreas Karakatsanis Textbook 2023 The Editor(s) (if appli [打印本頁(yè)] 作者: Daguerreotype 時(shí)間: 2025-3-21 16:19
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons影響因子(影響力)
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons影響因子(影響力)學(xué)科排名
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons網(wǎng)絡(luò)公開(kāi)度
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons網(wǎng)絡(luò)公開(kāi)度學(xué)科排名
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons被引頻次
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons被引頻次學(xué)科排名
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons年度引用
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons年度引用學(xué)科排名
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons讀者反饋
書(shū)目名稱(chēng)Breast Cancer Management for Surgeons讀者反饋學(xué)科排名
作者: Heretical 時(shí)間: 2025-3-21 21:26
Individuation — Acting on Victimhoodpplemental screening beyond mammography with various modalities, such as hand-held ultrasound (HHUS), automated breast ultrasound systems (ABUS), magnetic resonance imaging (MRI) and contrast-enhanced mammography (CEM) have been shown to improve breast cancer detection.作者: BILK 時(shí)間: 2025-3-22 01:17
Endocrine Regulation of Male Reproduction,procedure also excising most of the overlying skin or with varying extent of skin preservation. With the evolution of surgical techniques, skin and nipple-sparing mastectomy have gained popularity and are now considered standard of care when oncologically appropriate. This approach facilitates immed作者: 馬具 時(shí)間: 2025-3-22 06:03
The Genetics of Male Infertility, management of the axilla. It was seen that routine axillary dissection resulted in the retrieval of healthy lymph nodes in about 70% of cases, a percentage that has been stable despite all improvements that nowadays results in earlier diagnosis. This led to the value of axillary surgery as a routin作者: HEPA-filter 時(shí)間: 2025-3-22 09:07 作者: 否決 時(shí)間: 2025-3-22 16:04
https://doi.org/10.1007/978-1-4471-1300-3free survival (DFS) or even overall survival in certain subsets of patients. Surgery following PST is therefore a diagnostic procedure (assessment of tumor response in breast and axilla) as well as a therapeutic tool (locoregional control). Furthermore, it may improve surgical decision making in pat作者: 序曲 時(shí)間: 2025-3-22 20:53 作者: 剛毅 時(shí)間: 2025-3-22 22:28 作者: conscribe 時(shí)間: 2025-3-23 05:25
Imaging of the Breast and Screeningpplemental screening beyond mammography with various modalities, such as hand-held ultrasound (HHUS), automated breast ultrasound systems (ABUS), magnetic resonance imaging (MRI) and contrast-enhanced mammography (CEM) have been shown to improve breast cancer detection.作者: 印第安人 時(shí)間: 2025-3-23 08:45 作者: DEI 時(shí)間: 2025-3-23 10:57 作者: 尊重 時(shí)間: 2025-3-23 15:28 作者: Omniscient 時(shí)間: 2025-3-23 20:28
Breast Surgery After Primary Systemic Treatmentfree survival (DFS) or even overall survival in certain subsets of patients. Surgery following PST is therefore a diagnostic procedure (assessment of tumor response in breast and axilla) as well as a therapeutic tool (locoregional control). Furthermore, it may improve surgical decision making in pat作者: 親屬 時(shí)間: 2025-3-23 23:47
Axillary Surgery After Primary Systemic Therapyxillary staging after PST is the current standard of care for all breast cancers amenable to curative treatment. However, in contrast to the “upfront-surgery” setting, whether the extent of axillary surgery is foremost a staging procedure, axillary surgery post PST still yields unclarities with rega作者: Radiculopathy 時(shí)間: 2025-3-24 06:08 作者: 蝕刻 時(shí)間: 2025-3-24 07:19 作者: 不真 時(shí)間: 2025-3-24 13:42
Hereditary Breast Cancer. Risk- Assessment, Screening and Risk- Reduction Strategies syndromes should be discussed in a shared- decision making environment under the care of a multidisciplinary and interprofessional team of experts. As a result, patients are empowered to make educated, informed decisions regarding screening pathways, and cancer prevention.作者: HAIRY 時(shí)間: 2025-3-24 17:26 作者: sebaceous-gland 時(shí)間: 2025-3-24 20:39
breast component.The contents extract and distil the key mes.This book is a revision companion for the UEMS breast exam. The contents extract and distil the key messages and facts of the exam-linked textbook, published in 2017, giving self-test opportunities in the last chapter. Each chapter starts 作者: Armory 時(shí)間: 2025-3-24 23:54
Biopolitics — Imagining Victimhoodand exogenous oestrogens all having an impact. Despite the increased incidence, survival rates in the developed world are falling due to earlier diagnosis and better treatments. This chapter explores these issues in more detail. 作者: Vertical 時(shí)間: 2025-3-25 04:23
https://doi.org/10.1007/978-1-4419-0449-2 or lipofilling as an adjunct or alternative. Patients are increasingly faced with choices they previously didn’t have and shared decision-making taking into account patient, tumour and all treatment factors make this an exciting area for tailoring an individualised approach to optimise care for each patient.作者: adduction 時(shí)間: 2025-3-25 07:40 作者: 極為憤怒 時(shí)間: 2025-3-25 12:11 作者: synchronous 時(shí)間: 2025-3-25 17:20
Textbook 2023ublished in 2017, giving self-test opportunities in the last chapter. Each chapter starts by listing the key facts. The chapters have been edited by the exam board in collaboration with most of the authors of the original chapters of key relevance..The book is specifically designed to complement the作者: Ascendancy 時(shí)間: 2025-3-25 20:07 作者: 側(cè)面左右 時(shí)間: 2025-3-26 01:50 作者: 祝賀 時(shí)間: 2025-3-26 06:30 作者: 倔強(qiáng)一點(diǎn) 時(shí)間: 2025-3-26 10:01 作者: 單色 時(shí)間: 2025-3-26 15:20
Hereditary Breast Cancer. Risk- Assessment, Screening and Risk- Reduction Strategiesrs occur as a variant of high penetrance genes with an autosomal dominant pattern and are characterized by presentation of the disease at an earlier age. Identifying those groups of individuals that are high risk for breast cancer is of paramount importance as they could be promptly referred for gen作者: 試驗(yàn) 時(shí)間: 2025-3-26 19:03
Clinical Presentation, Diagnosis and Staging of Breast Canceriderably between countries and depends on the presence, quality and frequency of organized mammographic screening, access of the diagnostic imaging outside of the screening program and the level of breast cancer awareness in the population. The symptoms and signs of breast cancer, which vary conside作者: blister 時(shí)間: 2025-3-27 00:38
Breast Conservation Surgeryn to normal function than mastectomy (with or without reconstruction). Achievement of clear margins with even cT3 tumours or large volumes of DCIS with ever larger tumour to breast volume ratios has become possible owing to the development and increasing availability of oncoplastic methods including作者: 慟哭 時(shí)間: 2025-3-27 03:14
Mastectomy: Reconstructive Considerations and Strategiese disease when feasible to achieve oncological adequate margins and maintain the breast aesthetic. Despite advances in oncoplastic techniques and the increasing use of neoadjuvant systemic therapies that may broaden the scope of breast conservation, mastectomy is still playing an important role in b作者: 終止 時(shí)間: 2025-3-27 06:24
Axillary Surgery for Early Breast Cancerodal status is a strong prognosticator, next to primary tumor size and grade. Hence, axillary staging remains the standard of care for all breast cancers amenable to curative treatment. Initially, axillary surgery was viewed as a procedure that had a therapeutic effect and, initially, major and aggr作者: 寡頭政治 時(shí)間: 2025-3-27 10:31
Principles of Primary Systemic Therapy and targeted drugs, including endocrine therapy and HER2-targeting antibodies for ER-positive and HER2-positive BC, respectively. Although systemic therapies were initially developed post-operatively (adjuvant), their use has later expanded to the primary, pre-operative setting (neoadjuvant or prim作者: 移動(dòng) 時(shí)間: 2025-3-27 14:11 作者: 恃強(qiáng)凌弱 時(shí)間: 2025-3-27 21:13 作者: 性別 時(shí)間: 2025-3-28 00:32 作者: 刺穿 時(shí)間: 2025-3-28 03:34 作者: Flat-Feet 時(shí)間: 2025-3-28 06:27
Biopolitics — Imagining Victimhoodis the leading cause of cancer deaths among women (Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A, CA Cancer J Clin. 68:394–424, 2018). The incidence of BC has been steadily rising over the past 20?years, this increase can, in part, be explained by increased case finding due to scre作者: 匍匐 時(shí)間: 2025-3-28 14:16
Individuation — Acting on Victimhoodandomized controlled trials conducted in the past 40?years have established a reduction in the mortality rate of 25%–30%. A large Swedish study found a reduction by 41% in fatal cancers and by 25% in the incidence of advanced breast cancers within ten years, in women undergoing mammographic screenin作者: IRK 時(shí)間: 2025-3-28 14:47
https://doi.org/10.1007/978-3-319-52639-3athologists. They will assess the material provided to them, either cytology samples, biopsy specimens or surgical excision material, and will provide not only diagnosis, but a large quantity of clinically important information for each case. Whilst there is a wide range of potential breast lesion d作者: 發(fā)現(xiàn) 時(shí)間: 2025-3-28 22:36
Audrey H. Schnell,John S. Witters occur as a variant of high penetrance genes with an autosomal dominant pattern and are characterized by presentation of the disease at an earlier age. Identifying those groups of individuals that are high risk for breast cancer is of paramount importance as they could be promptly referred for gen作者: CRP743 時(shí)間: 2025-3-29 02:02 作者: 為現(xiàn)場(chǎng) 時(shí)間: 2025-3-29 05:09 作者: 概觀 時(shí)間: 2025-3-29 10:36 作者: 玷污 時(shí)間: 2025-3-29 12:23 作者: 詩(shī)集 時(shí)間: 2025-3-29 17:46 作者: 極微小 時(shí)間: 2025-3-29 22:26
Male Reproductive Function and Semenguiding adjuvant treatment decisions. MGAs differ in terms of the technological platform used, the specific genes assessed, and the patient populations in which they were developed and validated. This chapter provides an overview of the most commonly used MGAs in clinical practice.作者: 粗糙濫制 時(shí)間: 2025-3-30 03:46 作者: excrete 時(shí)間: 2025-3-30 06:30 作者: 簡(jiǎn)略 時(shí)間: 2025-3-30 11:47
